Substrate
politics

Director of National Intelligence Reviews US Funding of More Than 120 Biolabs Abroad

Director of National Intelligence Tulsi Gabbard is investigating more than 120 biological laboratories in over 30 countries that received US funding for decades. The review covers research including gain-of-function experiments on pathogens and follows an executive order aimed at ending potentially risky virus studies.

New York Post
1 source·May 11, 7:01 PM(17 days ago)·2m read
Director of National Intelligence Reviews US Funding of More Than 120 Biolabs AbroadNew York Post
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

Director of National Intelligence Tulsi Gabbard has begun an investigation into more than 120 biological laboratories abroad funded by US taxpayer dollars for decades. The review is intended to assess research at the facilities, including gain-of-function experiments that could increase virus transmissibility, and follows President Trump’s executive order on such work.

Under guidance from Gabbard, the US Intelligence Community will examine activities at all US-funded biolabs. This includes both experiments that could enhance pathogen dangers and defensive research aimed at countering them. Office of the Director of National Intelligence officials stated that the labs are located in more than 30 countries.

More than 40 of the biolabs under review are in Ukraine. Officials noted these facilities could be at risk of compromise due to Russia’s war. Many received past funding through a Department of Defense program established after the Cold War to dispose of weapons of mass destruction.

The research falls under the Defense Department’s Cooperative Threat Reduction Program. It is aimed at studying pathogens to prevent future outbreaks and improving biosecurity. Officials said clinical trials at the biolabs are raising significant ethical, financial and security concerns.

Critics have pointed to lax oversight of funding that flows through US agencies to grantees and subawardees. This structure, they argue, limits public knowledge of whether dangerous experiments are occurring. The Defense Department’s watchdog previously could not determine how many enhanced potential pandemic pathogens were under study in China or other nations despite more than $1.4 billion spent on such experiments outside the US between 2014 and 2023.

2014 and 2021, US-funded experiments on bat coronaviruses at the Wuhan Institute of Virology violated grant terms by making viruses 10,000 times more infectious, according to the National Institutes of Health. Officials have denied that the research caused the COVID-19 pandemic.

The Biden administration denied the existence of US-owned or US-operated chemical or biological laboratories in Ukraine in a March 9, 2022 statement. It described related claims as Chinese and Russian propaganda issued shortly after the Russian invasion began.

Office of the Director of National Intelligence officials said these denials formed part of an Information Resilience strategy that sought to shape the public narrative and downplay US ties to the research. Secretary of War Pete Hegseth said the current administration is addressing issues from prior years.

“The prior administration bankrolled dangerous Gain-of-Function research and foreign biolabs with American tax dollars, then deliberately hid it from the American people,” Hegseth said in a statement. Gabbard stated that the COVID-19 pandemic showed the global impact of research on dangerous pathogens in biolabs.

She added that despite those dangers, such work continued.

Key Facts

120+ biolabs
funded by US in over 30 countries
40+ labs in Ukraine
at risk due to ongoing war
$1.4 billion
spent on foreign experiments 2014-2023
Wuhan experiments
made viruses 10000 times more infectious

Story Timeline

3 events
  1. 2026-05-11

    Director of National Intelligence Tulsi Gabbard launches review of over 120 US-funded biolabs abroad.

    1 sourceNew York Post
  2. March 9, 2022

    Biden administration denied existence of US-owned or operated biological labs in Ukraine.

    1 sourceNew York Post
  3. 2014-2023

    More than $1.4 billion spent on experiments outside the US, including bat coronavirus work in Wuhan.

    1 sourceNew York Post

Potential Impact

  1. 01

    US Intelligence Community will conduct formal review of all overseas biolab research activities.

  2. 02

    Possible policy shifts on gain-of-function research conducted with US funds abroad.

  3. 03

    Further declassification of documents related to past biolab activities and grants.

Transparency Panel

Sources cross-referenced1
Confidence score65%
Synthesized bySubstrate AI
Word count447 words
PublishedMay 11, 2026, 7:01 PM
Bias signals removed3 across 2 outlets
Signal Breakdown
Loaded 2Editorializing 1

Related Stories

Trump Meets Advisers to Decide on Iran Ceasefire ExtensionBBC News
politics1 hr ago

Trump Meets Advisers to Decide on Iran Ceasefire Extension

President Trump said he is holding a Situation Room meeting to make a final decision on a possible deal with Iran. The proposed agreement would extend the ceasefire by 60 days and reopen the Strait of Hormuz.

Al Jazeera
JA
MA
AF
AJ
+6
11 sources
Trump to Decide on Iran Deal in Situation Room Meetingmiddleeasteye.net
politics1 hr ago

Trump to Decide on Iran Deal in Situation Room Meeting

President Trump said Friday he is heading into the Situation Room to make a final determination on a potential agreement with Iran. The proposed deal would reopen the Strait of Hormuz without tolls and require destruction of Iran's highly-enriched uranium.

LI
Just the News
CBS News
3 sources
Vietnam Clears Graves for Trump Organization Project in Hung Yen Provincebenzinga.com
politics1 hr ago

Vietnam Clears Graves for Trump Organization Project in Hung Yen Province

Farmers in Hung Yen province are exhuming family graves to make way for a $1.5 billion Trump Organization development that includes hotels, villas and a golf course. The project, approved last year, has drawn local resistance over compensation levels and relocation of remains.

The Independent
1 source